ROCKET PHARMACEUTICALS, INC. — Investor Relations & Filings
Rocket Pharmaceuticals, Inc. is a fully integrated, late-stage biotechnology company that develops gene therapies for rare and devastating diseases. The company's mission is to provide cures by correcting the root cause of disease at the genetic level. It utilizes a multi-platform approach, employing both ex vivo lentiviral (LV) and in vivo adeno-associated viral (AAV) technologies. This strategy allows for the selection of the most suitable platform for specific conditions, with a focus on diseases with high unmet needs, including bone marrow-derived and cardiovascular disorders. Rocket aims to advance a sustainable pipeline of first-in-class investigational genetic therapies for patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Regulatory Filings 2019 | 2019-05-09 | English | |
| 10-Q | 2019-05-09 | English | |
| DEFA14A | 2019-04-30 | English | |
| DEF 14A | 2019-04-30 | English | |
| Director's Dealing 2019 | 2019-04-26 | English | |
| SCHEDULE 13D/A | 2019-04-18 | English |
Browse filings by year
18 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2019
15 filings
| |||||
| 11664430 | Regulatory Filings 2019 | 2019-05-09 | English | ||
| 11664431 | 10-Q | 2019-05-09 | English | ||
| 11664432 | DEFA14A | 2019-04-30 | English | ||
| 11664433 | DEF 14A | 2019-04-30 | English | ||
| 11664434 | Director's Dealing 2019 | 2019-04-26 | English | ||
| 11664435 | SCHEDULE 13D/A | 2019-04-18 | English | ||
| 11664436 | FORM 4 | 2019-04-18 | English | ||
| 11664438 | FORM 8-K | 2019-04-18 | English | ||
| 11664439 | 424B5 | 2019-04-17 | English | ||
| 11664437 | 424B5 | 2019-04-15 | English | ||
| 11664440 | 10-K | 2019-03-08 | English | ||
| 11664441 | FORM 4 | 2019-03-06 | English | ||
| 11664443 | Major Shareholding Notification 2019 | 2019-02-14 | English | ||
| 11664442 | SC 13G/A | 2019-02-14 | English | ||
| 11664444 | AMENDMENT NO. 1 | 2019-02-14 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
ROCKET PHARMACEUTICALS, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33148/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33148 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33148 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33148 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33148}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ROCKET PHARMACEUTICALS, INC. (id: 33148)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.